相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cordycepin induces M1/M2 macrophage polarization to attenuate the liver and lung damage and immunodeficiency in immature mice with sepsis via NF-κB/p65 inhibition
Yudan Zhang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2022)
Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14
Ya-jun Fu et al.
ACTA PHARMACOLOGICA SINICA (2021)
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Jianxiong Ji et al.
CELL DEATH AND DIFFERENTIATION (2021)
Utx Regulates the NF-κB Signaling Pathway of Natural Stem Cells to Modulate Macrophage Migration during Spinal Cord Injury
Miao Li et al.
JOURNAL OF NEUROTRAUMA (2021)
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
Nikhil Hirani et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Lactucopicrin Inhibits Cytoplasmic Dynein-Mediated NF-κB Activation in Inflammated Macrophages and Alleviates Atherogenesis in Apolipoprotein E-Deficient Mice
Luanying He et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2021)
Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy
Lisa Dannenberg et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Resveratrol inhibits macrophage infiltration of pancreatic islets in streptozotocin-induced type 1 diabetic mice via attenuation of the CXCL16/NF-κB p65 signaling pathway
Mostafa A. Darwish et al.
LIFE SCIENCES (2021)
Ketogenic Diet Suppressed T-Regulatory Cells and Promoted Cardiac Fibrosis via Reducing Mitochondria-Associated Membranes and Inhibiting Mitochondrial Function
Jun Tao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
Milica Velickovic et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cardiac fibrosis
Nikolaos G. Frangogiannis
CARDIOVASCULAR RESEARCH (2021)
Genetic Deletion of Galectin-3 Alters the Temporal Evolution of Macrophage Infiltration and Healing Affecting the Cardiac Remodeling and Function after Myocardial Infarction in Mice
Pablo Cassaglia et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Basic Mechanisms of Diabetic Heart Disease
Rebecca H. Ritchie et al.
CIRCULATION RESEARCH (2020)
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C. Petrie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
So Ra Kim et al.
NATURE COMMUNICATIONS (2020)
MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy
Yi Wang et al.
NATURE COMMUNICATIONS (2020)
Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway
Geng-Rui Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Progranulin inhibits LPS-induced macrophage M1 polarization via NF-kB and MAPK pathways
Lianlian Liu et al.
BMC IMMUNOLOGY (2020)
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
Diana Lindner et al.
JAMA CARDIOLOGY (2020)
Protective Effects of Thalidomide on High-Glucose-Induced Podocyte Injury through In Vitro Modulation of Macrophage M1/M2 Differentiation
Hui Liao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Effects of Anchomanes difformis on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
Toyin D. Alabi et al.
BIOMEDICINES (2020)
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
Vajir Malek et al.
CARDIOVASCULAR RESEARCH (2019)
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri T. Kato et al.
CIRCULATION (2019)
Diabetic Cardiomyopathy What Is It and Can It Be Fixed?
Wolfgang H. Dillmann
CIRCULATION RESEARCH (2019)
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Michael G. Dorrington et al.
FRONTIERS IN IMMUNOLOGY (2019)
Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies
Helena C. Kenny et al.
CIRCULATION RESEARCH (2019)
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li et al.
PHYTOMEDICINE (2019)
Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy
Aina He et al.
TRANSLATIONAL RESEARCH (2019)
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Henrik Svanstrom et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Piero Baglioni
NEW ENGLAND JOURNAL OF MEDICINE (2019)
IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction
Kohsuke Shirakawa et al.
CIRCULATION (2018)
Cardiac macrophages promote diastolic dysfunction
Maarten Hulsmans et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation
John A. Marwick et al.
CELL DEATH & DISEASE (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Beibei Luo et al.
FRONTIERS IN PHYSIOLOGY (2017)
Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning
Geoffrey de Couto et al.
CIRCULATION (2017)
Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
Mitchel Tate et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Guanghong Jia et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure
Freja Stoltze Gaborit et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Pingping Li et al.
CELL (2016)
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
Giuseppe Vergaro et al.
HYPERTENSION (2016)
High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway
Cheng-I Cheng et al.
CELLULAR SIGNALLING (2015)
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
SIRT1 Is a Regulator in High Glucose-Induced Inflammatory Response in RAW264.7 Cells
Yanhui Jia et al.
PLOS ONE (2015)
TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy
Jin Ma et al.
PLOS ONE (2014)
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Liu-cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
Karina Huynh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Galectin-3: its role in asthma and potential as an anti-inflammatory target
Peng Gao et al.
RESPIRATORY RESEARCH (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy
Yuan Zhang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
Natalia Lopez-Andres et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Regulation of NF-κB by ubiquitination and degradation of the IκBs
Naama Kanarek et al.
IMMUNOLOGICAL REVIEWS (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Galectins: regulators of acute and chronic inflammation
Fu-Tong Liu et al.
YEAR IN IMMUNOLOGY 2 (2010)
Deficiency of Rac1 Blocks NADPH Oxidase Activation, Inhibits Endoplasmic Reticulum Stress, and Reduces Myocardial Remodeling in a Mouse Model of Type 1 Diabetes
Jianmin Li et al.
DIABETES (2010)
Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
Wilfried Dinh et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling
Pawel Zymek et al.
CARDIOVASCULAR RESEARCH (2007)
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus
D. Westermann et al.
DIABETOLOGIA (2006)
Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction
O Dewald et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury
NG Frangogiannis et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
